InMode to Participate in Investor Conferences in March 2022

YOKNEAM, Israel, March 2, 2022 /PRNewswire/ --InMode Ltd.(Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate in the following investor conferences in March.

Oppenheimer 32nd Annual Healthcare Conference

Format: Virtual fireside chat and one-on-one meetings
When: Fireside chat scheduled for 10:40 a.m. EST on Tuesday, March 15
A live webcast of the presentation can be accessed here.

Barclays Global Healthcare Conference

Format: In-person presentation and one-on-one meetings
Location: Loews Miami Beach Hotel, Miami Beach, Florida
When: Presentation scheduled for 9:00 a.m. EST on Thursday, March 17
A live webcast of the presentation can be accessed here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
+ 1 (0) 917-607-8654

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-investor-conferences-in-march-301493343.html

SOURCE InMode Ltd.

Company Codes: NASDAQ-NMS:INMD